Home/ Stocks/ NMTC

NeuroOne Medical Technologies Corporation Common Stock

NMTC XNAS

$1.63 +0.06 (+3.87%) ▲ 15-min delayed

Open

$1.56

High

$1.63

Low

$1.42

Volume

156.6K

Market Cap

$13.49M

About NeuroOne Medical Technologies Corporation Common Stock

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 18 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$2.39M	$-2,085,669	$-0.25
Q1 2026	$2.89M	$-1,437,890	$-0.03
FY 2025	$9.10M	$-3,605,374	$-0.09
Q3 2025	$1.70M	$-1,500,868	$-0.03

Related Market News

No specific coverage for NMTC yet. Check out our latest market news or earnings calendar.

Get NMTC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NeuroOne Medical Technologies Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.